Back
Madrigal Pharmaceuticals, Inc. 10K Form
Buy
68
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$586.25
Seasonality Move:
22.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MDGL News And Ratings
See the #1 stock for the next 7 days that we like better than MDGL
MDGL Financial Statistics
Sales & Book Value
| Annual Sales: | $180.1M |
|---|---|
| Cash Flow: | $76M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $27.56 |
| Price / Book: | 21.05 |
Profitability
| EPS (TTM): | -13.00770 |
|---|---|
| Net Income (TTM): | $-289.1M |
| Gross Margin: | $172.8M |
| Return on Equity: | -40.56% |
| Return on Assets: | -26.33% |
Madrigal Pharmaceuticals, Inc. Earnings Forecast
Key Madrigal Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 23 years for MDGL is 95.93%.
-
The Selling, General & Administrative Expenses for MDGL have been equal to 241.52% of Gross Profit Margin.
-
The Research & Development expenses have been 130.80% of Revenue.
-
The Net Earning history of MDGL is -258.64% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 8 years.
Madrigal Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MDGL |
| CUSIP: | 558868 |
| Website: | madrigalpharma.com |
Debt
| Debt-to-Equity Ratio: | 0.55 |
|---|---|
| Current Ratio: | 3.44 |
| Quick Ratio: | 3.14 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 150.49 |
MDGL Technical Analysis vs Fundamental Analysis
Buy
68
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy or a Sell?
-
Madrigal Pharmaceuticals, Inc. stock is rated a BuyThe current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $579.89. The Score for MDGL is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.